That's interesting, I hadn't considered that viewpoint. Cheers
Three follow up questions that come to mind.
- Why do you think the two sides will be too far apart to reach agreement?
- Do you think having multiple large pharma groups competing for Bisantrene will change this prediction?
- How do you incorporate other pharma transactions that have occured without prior partnerships into this view?
What's going on with Race Oncology at the moment ?, page-43
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |